Masimo’s LiDCO Advanced Hemodynamic Monitoring Earns EU Nod

Masimo has earned CE mark certification for its LiDCO board-in-cable (BIC) module. The LiDCO BIC connects to multi-patient monitoring platforms like Masimo Root patient monitoring and connectivity hub for advanced hemodynamic monitoring.
 
The solution lets clinicians add the PulseCO algorithm for hemodynamic monitoring. The LiDCO module is pressure transducer agnostic and supports guided protocols to assess fluid responsiveness, rich trending data, and notifications for beat-by-beat pressure analysis.
 
Joe Kiani, founder and CEO of Masimo, told the press, “Bringing LiDCO’s beat-to-beat advanced hemodynamic monitoring to Masimo Root opens up the possibility of providing a more complete, continuous picture of cardiac output (CO) and oxygen delivery (DO₂). Currently, hemodynamic monitors can provide continuous analysis of blood pressure information but rely on intermittent data from other monitors for oxygenation—giving clinicians only half of the information.
 
The LiDCO module uses an existing arterial line and blood pressure transducer to monitor hemodynamic parameters with the PulseCO algorithm. Beat-by-beat analysis, according to Masimo, can provide more immediate feedback about fluid and hemodynamic status and avoid assumptions about vascular compliance or detection of the dicrotic notch.
 
Its board-in-cable design makes it compatible with the Root monitor and other multiparameter platforms, removing the need for a dedicated hemodynamic monitor in the OR or ICU. Masimo said In clinical studies, using LiDCO was shown to lower postoperative complications, costs, and mortalities at 30 and 180 days after surgery.
 
“Using both Masimo’s breakthrough noninvasive rainbow SET Pulse CO-Oximetry parameters and LiDCO’s innovative PulseCO algorithm, clinicians now have the ability to view a continuous and simultaneous display of all the components that make up a patient’s oxygen delivery, DO₂—such as cardiac output (CO), stroke volume (SV), pulse rate (PR), total hemoglobin (Masimo SpHb), and fractional oxygen saturation (Masimo SET SpO₂ adjusted for dyshemoglobins, SpCO, and SpMet)—alongside an automated estimation of DO₂,” Kiani went on. “These can be displayed side by side, in real time and continuously, on Root’s high-resolution screen. We are excited about what this means for surgical and critical care patients whose clinicians can finally view real-time continuous data from the breakthrough combination of LiDCO and rainbow, working synergistically together as an indication of continuous oxygen delivery.”